The purpose of the study was to assess whether there was an increased rate of congenital anomalies or significant developmental delay in infants of women with epilepsy who had been treated with carbamazepine during pregnancy.
Department of Anatomy and Cell Biology, Jerusalem Institute of Child Development, Hebrew University Hadassah Medical School and Ministry of Health, Israel.